CHRW
C.H. Robinson
$148.45
▲ 1.2%Updated Aug 7, 11:30 AM ET
CHRW at a glance — five pillars scored 0–100 from real filed financials.
Overall: Neutral · 44/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 98.1% over the last 12 months
Market Cap
$22.38B
P/E
29.2x
Forward P/E (est.)
24.75x
ROE
33.3%
Revenue Growth
-6.7%
EPS Growth
18.0%
Profit Margin
3.7%
FCF Yield
2.2%
Debt / Equity
0.59x
ROIC
21.0%
Interest Coverage
—
Current Ratio
1.59x
Dividend Yield
1.3%
Implied Growth (rev. DCF)
4.8%
Rating Score
44/100
C.H. Robinson (CHRW) is a large-cap company in the Air Freight & Logistics industry, part of the Industrials sector of the S&P 500, with a market value around $22.38B.
In its latest reported year it generated about $16.23B in revenue and $587.08M in net profit.
Our model rates CHRW Neutral (44/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (10 years of history).
Some durable-advantage evidence, but not across the board — dig into which ingredient is weak and whether it's cyclical or structural.
3.9% average over the last 3 years
±0.9 pts around 4.8% across 10 years
grew in 6 of the last 9 year-over-year periods
positive in 10 of 10 years
21.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CHRW's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CHRW trades near $148.45, below its 50-day average ($179.66) and 200-day average ($166.17). Price below both averages is a downtrend — momentum is against buyers for now.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 48 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently positive — short-term momentum is improving.
Volatility — ATR. Average True Range is the typical daily move. CHRW's is $5.86 (~3.9% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month CHRW found buyers near $175.84 (support) and sellers near $195.00 (resistance); its 52-week range is $96.27–$203.34. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.8× the 20-day average — about normal. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
-8.4%
Revenue moved from $13.14B in 2016 to $16.23B in 2025, a 2.4% compound annual growth rate. The most recent year declined 6.7% year over year. Shrinking revenue is worth a closer look — is it cyclical or structural?
Gross Margin
16.8%
Operating Margin
4.9%
Net Margin
3.6%
ROE
33.3%
C.H. Robinson keeps about 3.7% of each sales dollar as net profit, with a 16.8% gross margin and 4.9% operating margin. Return on equity is 33.3% and return on invested capital about 21.0%. Thin margins leave less cushion if costs rise.
Total Debt
$1.34B
Net Debt
$1.18B
Net Debt / EBITDA
1.49x
Debt / Equity
0.59x
Leverage: debt-to-equity is 0.6x, with a current ratio of 1.6x. That is a moderate, manageable debt load for most businesses. It carries roughly $1.34B of total debt against $159.66M of cash.
Operating CF
$914.52M
Free Cash Flow
$894.89M
FCF Margin
5.5%
In the latest year C.H. Robinson produced about $914.52M of operating cash flow and $894.89M of free cash flow after capital spending. That is a free-cash-flow yield of about 2.2% on today's price. Cash flow is what ultimately pays shareholders, so it is worth tracking over time.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The payout is comfortably covered by cash the business actually generates, with a raise habit behind it.
Dividend yield
1.3%
Per share (latest FY)
$2.49
Total paid (latest FY)
$301.38M
History on record
10 years
dividend uses 34% of free cash flow
51% of net income paid out
total dividends increased 5 years in a row
payout was cut at least once in the last 10 years
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
29.2x
P/S
1.37x
P/B
8.07x
EV / EBITDA
—
CHRW trades at 29.2x trailing earnings (about 24.8x on estimated forward earnings), 1.4x sales, and 8.1x book value. Reverse-engineering today's price implies the market expects roughly 4.8% long-term free-cash-flow growth. That is a premium multiple that needs growth to justify it.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$77.91
Current price
$148.45
Starting FCF (latest 10-K)
$894.89M
Growth, years 1–5
-5.0%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where CHRW sits versus its Industrials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 144 Industrials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How CHRW stacks up against its Industrials peers — valuation, profitability, and growth versus the sector median.
In the Industrials sector (273 S&P 500 companies), CHRW ranks #99 of 273 by our overall rating. It trades at roughly in line versus the sector on earnings (29.2x P/E vs. 32x median) with a higher return on equity (33.3% vs. 18.1%) and slower revenue growth (-6.7% vs. 6.0%).
P/E vs sector
29.2x
median 32x
ROE vs sector
33.3%
median 18.1%
Growth vs sector
-6.7%
median 6.0%
Sector rank
#99
of 273 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Industrials companies by sub-industry and size. Sector median is across all 273 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $148.45 today · expected CAGR -11% – -0%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $16.72B | $17.22B | $17.74B | $18.27B | $18.82B |
| Net income | $668.79M | $688.85M | $709.52M | $730.80M | $752.73M |
| EPS | $4.44 | $4.57 | $4.71 | $4.85 | $4.99 |
| Share price (low) | $75.42 | $77.68 | $80.01 | $82.41 | $84.89 |
| Share price (high) | $128.66 | $132.52 | $136.50 | $140.59 | $144.81 |
| CAGR (low–high) | -49% / -13% | -28% / -6% | -19% / -3% | -14% / -1% | -11% / -0% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for CHRW:
- Strong return on equity (33.3%) shows capital is put to work well.
- As an established S&P 500 member in Industrials, it brings scale and a long operating history.
The case against CHRW:
- Revenue growth is slow/negative (-6.7%), limiting the upside engine.
- Thin net margins (3.7%) leave little room for error.
Growth risk — sluggish revenue (-6.7%) leaves little margin for execution missteps.
Margin risk — thin profitability (3.7%) is vulnerable to cost or pricing pressure.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the picture is mixed: C.H. Robinson is a large-cap industrials business with shrinking revenue, with modest profitability, and a sound balance sheet. It trades at 29.2x earnings, which our model scores Neutral (44/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 32 Wall Street analysts covering CHRW recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more positive over the last three months (+6 pts of buy ratings).
Latest SEC Filings
CHRW's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
CHRW — frequently asked questions
Is CHRW a good stock to buy?
We don't give buy or sell advice. Our model rates C.H. Robinson Neutral (44/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is CHRW's rating on The Stocks School?
C.H. Robinson currently scores 44/100 (Neutral) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does CHRW's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from C.H. Robinson's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for CHRW calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this CHRW analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CHRW. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.